TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23771586

Group type: EXPERIMENTAL
Intervention: Wrist path analysis during spatial pointing movements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wrist speed profiles
Number of subjects: 0
Study: 22134452

Group type: EXPERIMENTAL
Intervention: PTSD numbing and hyperarousal symptom clusters
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: PTSD symptom clusters
Number of subjects: 943
Study: 18534406

Group type: EXPERIMENTAL
Intervention: Digital radiographs for assessing postoperative component SSA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Digital radiographs for assessing preoperative NSA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Synthetic femur positioned in 10 degrees increments of either flexion or rotation
Number of subjects: 15
Study: 17456482

Group type: EXPERIMENTAL
Intervention: Enoxaparin (ENOX)
Number of subjects: 20479

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 20479
Study: 14990643

Group type: EXPERIMENTAL
Intervention: CTRT (pelvic radiotherapy with concomitant fluorouracil and cisplatin)
Number of subjects: 403

Group type: COMPARATOR
Intervention: EFRT (extended-field radiotherapy)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: CTRT
Number of subjects: 403
Study: 11843231

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tretinoin gel 0.025%
Number of subjects: 150
Study: 8988956

Group type: EXPERIMENTAL
Intervention: Pindolol (5.0 mg b.i.d. or 2.5 mg t.i.d.)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pindolol and Placebo
Number of subjects: 43
Study: 8237986

Group type: EXPERIMENTAL
Intervention: Monetary incentive (10 Swiss francs) and reminder card
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Monetary incentive only
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Reminder card only
Number of subjects: 1235

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Both incentives in follow-up mailings
Number of subjects: 1235
Study: 3655634

Group type: EXPERIMENTAL
Intervention: Diet group (carbohydrate restriction to 120 g daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No diet group (limit use of table sugar)
Number of subjects: 0
Study: 31915086

Group type: EXPERIMENTAL
Intervention: Unhealthy food branding
Number of subjects: 1331

Group type: EXPERIMENTAL
Intervention: Healthier food branding
Number of subjects: 1331

Group type: EXPERIMENTAL
Intervention: Public health nutrition campaign branding
Number of subjects: 1331

Group type: COMPARATOR
Intervention: Non-food branding (control)
Number of subjects: 1331
Study: 29891524

Group type: EXPERIMENTAL
Intervention: Early initiation of salvage androgen deprivation therapy (ADT) for post-radiation therapy PSA failure in men with PSA doubling time (PSA-DT) ≥6 months.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Increasing PSA-DT as a continuous covariate (per month increase).
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Short PSA-DT (<6 months) with salvage ADT initiation.
Number of subjects: 54
Study: 27627802

Group type: EXPERIMENTAL
Intervention: Endovascular repair
Number of subjects: 881

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 881
Study: 24301456

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 380

Group type: COMPARATOR
Intervention: 5-fluorouracil/folinic acid
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Gemcitabine with low hENT1 expression
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Gemcitabine with high hENT1 expression
Number of subjects: 380

Group type: COMPARATOR
Intervention: 5-fluorouracil with low hENT1 expression
Number of subjects: 380

Group type: COMPARATOR
Intervention: 5-fluorouracil with high hENT1 expression
Number of subjects: 380

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 380
Study: 23566058

Group type: EXPERIMENTAL
Intervention: Oligonol (100 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 17
Study: 19669856

Group type: EXPERIMENTAL
Intervention: Laser phototherapy (one session per week for 10 weeks, 780 nm, 60 mW, 3.0 J/cm² or 4.5 J/cm²)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Topical aciclovir treatment (control group)
Number of subjects: 71
Study: 18684176

Group type: EXPERIMENTAL
Intervention: Direct Observed Therapy (DOT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-Administration (SA)
Number of subjects: 48
Study: 17127546

Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Modafinil 800 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mg IV cocaine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg IV cocaine
Number of subjects: 12
Study: 14661072

Group type: EXPERIMENTAL
Intervention: Anatomic Benoist Girard (ABG) femoral stem
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mallory‐Head (MH) femoral stem
Number of subjects: 60
Study: 10950408

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Natural course of the disease
Number of subjects: 0
Study: 9055771

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound-guided catheterization
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard landmark-oriented approach
Number of subjects: 20
Study: 8373604

Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol 2.4 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midazolam 0.3 mg/kg
Number of subjects: 90
Study: 2938518

Group type: EXPERIMENTAL
Intervention: 0.14 mg/kg of midazolam (midazolam hydrochloride 5 mg/ml)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.29 mg/kg diazepam (Valium 5 mg/ml)
Number of subjects: 50
Study: 31567817

Group type: EXPERIMENTAL
Intervention: Anti-VEGF therapy
Number of subjects: 883

Group type: COMPARATOR
Intervention: Laser photocoagulation, sham, or intravitreal saline (Control)
Number of subjects: 883
Study: 28272105

Group type: EXPERIMENTAL
Intervention: Higher optical quality polish of prosthesis
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard polish of prosthesis
Number of subjects: 41
Study: 27309887

Group type: EXPERIMENTAL
Intervention: binimetinib
Number of subjects: 51
Study: 24965052

Group type: EXPERIMENTAL
Intervention: Therapist average alliance score
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Therapist experience conducting couple therapy
Number of subjects: 158

Group type: COMPARATOR
Intervention: Therapist gender
Number of subjects: 158

Group type: COMPARATOR
Intervention: Therapist discipline
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Therapist average alliance score and experience
Number of subjects: 158
Study: 22965591

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab with prompt laser treatment
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab with deferred laser treatment
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 361
Study: 20537319

Group type: EXPERIMENTAL
Intervention: Indicated cognitive‐behavioral depression prevention program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Assessment-only controls
Number of subjects: 300
Study: 18502245

Group type: EXPERIMENTAL
Intervention: Cognitive therapy for depression
Number of subjects: 24
Study: 17092253

Group type: EXPERIMENTAL
Intervention: RR/RH genotypes of FcgammaRIIa in SLE patients
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: RR/RH genotypes of FcgammaRIIa and ACC/ACC haplotype of IL‐10
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: FcgammaRIIa, RR homozygotes
Number of subjects: 195
Study: 12783149

Group type: EXPERIMENTAL
Intervention: Open-loop responses starting from A at the right endpoint of the segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closed-loop responses from A at the right endpoint of the segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open-loop responses from A at the left endpoint of the segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open-loop responses from A aligned horizontally with the left endpoint of the segment but displaced vertically below that segment
Number of subjects: 0
Study: 10085542

Group type: EXPERIMENTAL
Intervention: Jorvik museum odours
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control odours
Number of subjects: 3

Group type: COMPARATOR
Intervention: No odours
Number of subjects: 3
Study: 10162148

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACE-Is)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ACE-Is for patients with ejection fraction ≤ 40%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ACE-Is for patients with ejection fraction > 40%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 100

Group type: COMPARATOR
Intervention: Documentation of left ventricular function
Number of subjects: 100

Group type: COMPARATOR
Intervention: Use of ACE-Is for patients with ejection fraction ≤ 40%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Use of calcium channel blockers and beta blockers
Number of subjects: 100
Study: 2058666

Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate, 250 mg four times daily for 3 days
Number of subjects: 20
Study: 6651284

Group type: EXPERIMENTAL
Intervention: azlocillin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no azlocillin)
Number of subjects: 20
Study: 30903962

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 60
Study: 28810355

Group type: EXPERIMENTAL
Intervention: Cognitive-affective preparation session
Number of subjects: 128

Group type: COMPARATOR
Intervention: General health education session
Number of subjects: 128
Study: 27505305

Group type: EXPERIMENTAL
Intervention: SAPT with PLGM (predictive algorithm)
Number of subjects: 25

Group type: COMPARATOR
Intervention: SAPT alone (control)
Number of subjects: 25
Study: 25270545

Group type: EXPERIMENTAL
Intervention: Fixed-volume implant in 1 breast and an adjustable-volume implant in the other
Number of subjects: 60

Group type: COMPARATOR
Intervention: Two fixed-volume implants of different sizes
Number of subjects: 60
Study: 22920839

Group type: EXPERIMENTAL
Intervention: Sling exercise therapy (ST)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional physiotherapy (PT)
Number of subjects: 50
Study: 20703977

Group type: EXPERIMENTAL
Intervention: Thera‐Band (®) Exercise Station Group (TBG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Weight machines/free weights group (MFWG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study: 16973668

Group type: EXPERIMENTAL
Intervention: Hypotonic 0.18% sodium hyaluronate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic 0.3% hydroxypropyl‐methylcellulose (HPMC)/0.1% dextran
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of sodium hyaluronate vs HPMC/dextran
Number of subjects: 10
Study: 15774341

Group type: EXPERIMENTAL
Intervention: Supervised group exercise programme (12-week intervention)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no exercise programme)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Supervised group exercise programme
Number of subjects: 22
Study: 12230149

Group type: EXPERIMENTAL
Intervention: Computer games involving MR skills (experimental group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Computer games not involving MR skills (control group)
Number of subjects: 47
Study: 10212855

Group type: EXPERIMENTAL
Intervention: Azelastine eye drops
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8652692

Group type: EXPERIMENTAL
Intervention: Voluntary HIV counselling and testing (IC group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (AC group)
Number of subjects: 0
Study: 2363529

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg of dTC
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 60
Study: 527353

Group type: EXPERIMENTAL
Intervention: sulphinpyrazone
Number of subjects: 7

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7
Study: 30888702

Group type: EXPERIMENTAL
Intervention: Anti-RPA194 antibodies
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Anti-RPC155 with anti-RPA194
Number of subjects: 168
Study: 29061612

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (RA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 1000
Study: 25009199

Group type: EXPERIMENTAL
Intervention: Gait training with auditory feedback for 30 minutes, five times a week for four weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Gait training without auditory feedback for 30 minutes, five times a week for four weeks
Number of subjects: 22
Study: 24597923

Group type: EXPERIMENTAL
Intervention: Virtual learning environment courseware package
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional learning (lecture-based training)
Number of subjects: 35
Study: 21603859

Group type: EXPERIMENTAL
Intervention: HFR dialysis (n=25)
Number of subjects: 40

Group type: COMPARATOR
Intervention: HD-PS dialysis (n=15)
Number of subjects: 40
Study: 20387748

Group type: EXPERIMENTAL
Intervention: Biatrial pacing
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 210

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 210
Study: 17449511

Group type: EXPERIMENTAL
Intervention: HP-FSH
Number of subjects: 151

Group type: COMPARATOR
Intervention: rFSH
Number of subjects: 151
Study: 16331341

Group type: EXPERIMENTAL
Intervention: TENS (transcutaneous electrical nerve stimulation) used postoperatively on 60 patients for 5 days.
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (56 patients without TENS).
Number of subjects: 116
Study: 12466925

Group type: EXPERIMENTAL
Intervention: Central Capacity Sharing model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Central Bottleneck model
Number of subjects: 0
Study: 9695722

Group type: EXPERIMENTAL
Intervention: Urodilatin infusion (7.5 to 15 to 30 ng.kg body weight‐1.min‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7734467

Group type: EXPERIMENTAL
Intervention: Therapist/patient matching by gender and race for the intake interview
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Continuity by having the intake therapist become the treatment therapist
Number of subjects: 634

Group type: COMPARATOR
Intervention: Eight different therapists conducting intake interviews
Number of subjects: 634
Study: 2659955

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (50 mg i.m. every 3 weeks for 12 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29289931

Group type: EXPERIMENTAL
Intervention: Visual cues (color)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Informational cues (claim/label)
Number of subjects: 300
Study: 26847236

Group type: EXPERIMENTAL
Intervention: ImageJ‐based method
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Cumulus approach
Number of subjects: 765

Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 765
Study: 26555004

Group type: EXPERIMENTAL
Intervention: Nonweighted decisional balance intervention
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Weighted decisional balance intervention
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study: 23071237

Group type: EXPERIMENTAL
Intervention: RT/PCV (radiotherapy followed by six cycles of procarbazine, lomustine, and vincristine)
Number of subjects: 368

Group type: COMPARATOR
Intervention: RT (radiotherapy only)
Number of subjects: 368
Study: 20847618

Group type: EXPERIMENTAL
Intervention: Barrier retractional wound protection
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard wound retraction
Number of subjects: 130
Study: 18164988

Group type: EXPERIMENTAL
Intervention: Auditory attention experiment
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Visual attention experiment
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Hanoi experiment
Number of subjects: 66
Study: 17083882

Group type: EXPERIMENTAL
Intervention: Topical calcineurin inhibitors (pimecrolimus and tacrolimus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FDA black box warning on topical calcineurin inhibitors
Number of subjects: 0
Study: 14680078

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 320/9 microg
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Budesonide 400 microg
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Formoterol 9 microg
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1022
Study: 11679530

Group type: EXPERIMENTAL
Intervention: Intramural fibroids (n = 106 with fibroids ≤5 cm)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group (n = 322 without fibroids)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Presence of intramural fibroids
Number of subjects: 434
Study: 9467150

Group type: EXPERIMENTAL
Intervention: Follow-up by community optometrists
Number of subjects: 403

Group type: COMPARATOR
Intervention: Follow-up by hospital eye service
Number of subjects: 403
Study: 7941942

Group type: EXPERIMENTAL
Intervention: Ibuprofen 40 mg.kg‐1.d‐1, divided into four equal doses
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 2453705

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl-starch (200/0.5 10%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laevulose 5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Whole blood (no processing)
Number of subjects: 60
Study: 29209731

Group type: EXPERIMENTAL
Intervention: KAT plus a conventional rehabilitation programme
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional rehabilitation programme
Number of subjects: 64
Study: 28398347

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) from healthy donors or autologous faeces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 0
Study: 25992279

Group type: EXPERIMENTAL
Intervention: iloprost 2.5 µg
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: iloprost 5.0 µg
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: iloprost 2.5 µg or 5.0 µg in iPAH subset
Number of subjects: 126
Study: 24617227

Group type: EXPERIMENTAL
Intervention: Regulating spleen-stomach needling
Number of subjects: 144

Group type: COMPARATOR
Intervention: Regular treatment of diabetes (Control group)
Number of subjects: 144
Study: 21909606

Group type: EXPERIMENTAL
Intervention: Mtwo NiTi rotary system
Number of subjects: 97

Group type: COMPARATOR
Intervention: K file
Number of subjects: 97
Study: 18420953

Group type: EXPERIMENTAL
Intervention: Prophylactic Transluminal Balloon Angioplasty (pTBA)
Number of subjects: 170
Study: 16595025

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 11700

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 11700
Study: 12624551

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (20 ml 0.375% bupivacaine through L(3‐4) inter‐space)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anesthesia (4 mg.kg(‐1) thiopental and 1.5 mg.kg(‐1) succinylcholine)
Number of subjects: 30
Study: 11112112

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 9509181

Group type: EXPERIMENTAL
Intervention: Chloroquine/Chlorpheniramine combination
Number of subjects: 98

Group type: COMPARATOR
Intervention: Mefloquine
Number of subjects: 98
Study: 30386327

Group type: EXPERIMENTAL
Intervention: Dairy protein (UV-C treated)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Soy isoflavone protein (control)
Number of subjects: 21
Study: 27267111

Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study: 24862763

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude (HVLA) spinal manipulation (SM) in the treatment group (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo intervention in the control group (n=20)
Number of subjects: 40
Study: 22564228

Group type: EXPERIMENTAL
Intervention: Smart Negative Pressure (SNaP) Wound Care System
Number of subjects: 132

Group type: COMPARATOR
Intervention: Vacuum‐Assisted Closure (VAC) Therapy System
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both SNaP and VAC systems
Number of subjects: 132
Study: 19325998

Group type: EXPERIMENTAL
Intervention: Cold-water-spray
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CoolPack
Number of subjects: 24
Study: 16974175

Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 0
Study: 16295047

Group type: EXPERIMENTAL
Intervention: lercanidipine 10-20 mg/day
Number of subjects: 277

Group type: COMPARATOR
Intervention: ramipril 5-10 mg/day
Number of subjects: 277
Study: 11408852

Group type: EXPERIMENTAL
Intervention: Amoxicillin, 500 mg, three times daily for 7 days
Number of subjects: 129

Group type: COMPARATOR
Intervention: Azithromycin, 1 g, single dose
Number of subjects: 129
Study: 9457403

Group type: EXPERIMENTAL
Intervention: Inhaled IL-2 therapy (high-dose inhalation)
Number of subjects: 116
Study: 10150180

Group type: EXPERIMENTAL
Intervention: 3.75 U APSAC
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 7.5 U APSAC
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 15.0 U APSAC
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 30.0 U APSAC
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All APSAC groups
Number of subjects: 103

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 103